Literature DB >> 25367207

Impact of alpha- and beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance.

Emanuele Barbato1, Giovanna Sarno, Catalina Trana Berza, Giuseppe Di Gioia, Jozef Bartunek, Marc Vanderheyden, Luigi Di Serafino, William Wijns, Bruno Trimarco, Bernard De Bruyne.   

Abstract

We investigated the effect of β- and α-adrenergic blockers on fractional flow reserve (FFR) and index of microvascular resistance (IMR). In 43 patients (pts) with intermediate stenoses, we measured FFR and IMR before and after nonselective β-blocker propranolol (30 μg/kg, n = 20) and selective β1-blocker metoprolol (40 μg/kg, n = 23) IC; (b) In additional 21 pts after percutaneous coronary intervention (PCI), FFR and IMR were measured before and after α-blocker phentolamine (3 mg) IC. Neither propranolol nor metoprolol changed values of FFR and IMR. Phentolamine slightly decreased FFR (from 0.88 ± 0.05 to 0.87 ± 0.06, p = 0.025) but did not change IMR. FFR decreased from >0.80 to ≤0.80 in 3 pts (14%), but in none, the value decreased to <0.75. β-blockers do not affect FFR and IMR in intermediate stenoses. After PCI, a mild decrease in FFR occurs after α-blockers, though of limited clinical impact.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367207     DOI: 10.1007/s12265-014-9599-8

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  35 in total

Review 1.  Peri-interventional coronary vasomotion.

Authors:  Luisa Gregorini; Jean Marco; Gerd Heusch
Journal:  J Mol Cell Cardiol       Date:  2011-09-24       Impact factor: 5.000

Review 2.  From SYNTAX to FAME, a paradigm shift in revascularization strategies: the key role of fractional flow reserve in guiding myocardial revascularization.

Authors:  Fabio Mangiacapra; Emanuele Barbato
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2011-08       Impact factor: 2.160

3.  Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exercise in patients with coronary artery disease.

Authors:  A S Bortone; O M Hess; A Gaglione; T Suter; H Nonogi; J Grimm; H P Krayenbuehl
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

4.  High cholesterol levels are associated with coronary microvascular dysfunction.

Authors:  Fabio Mangiacapra; Bernard De Bruyne; Aaron J Peace; Narbeh Melikian; William Wijns; Emanuele Barbato
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2012-07       Impact factor: 2.160

5.  Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.

Authors:  Argyrios Ntalianis; Jan-Willem Sels; Giedrius Davidavicius; Nobuhiro Tanaka; Olivier Muller; Catalina Trana; Emanuele Barbato; Michalis Hamilos; Fabio Mangiacapra; Guy R Heyndrickx; William Wijns; Nico H J Pijls; Bernard De Bruyne
Journal:  JACC Cardiovasc Interv       Date:  2010-12       Impact factor: 11.195

6.  Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.

Authors:  Emanuele Barbato; Federico Piscione; Jozef Bartunek; Gennaro Galasso; Plinio Cirillo; Giuseppe De Luca; Guido Iaccarino; Bernard De Bruyne; Massimo Chiariello; William Wijns
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

7.  Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity.

Authors:  M Böttcher; J Czernin; K Sun; M E Phelps; H R Schelbert
Journal:  J Nucl Med       Date:  1997-03       Impact factor: 10.057

8.  Metoprolol does not effect myocardial fractional flow reserve in patients with intermediate coronary stenoses.

Authors:  Murat Ozdemir; Guliz Erdem Yazici; Sedat Turkoglu; Timur Timurkaynak; Atiye Cengel
Journal:  Int Heart J       Date:  2007-07       Impact factor: 1.862

9.  Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.

Authors:  L Gregorini; J Fajadet; G Robert; B Cassagneau; M Bernis; J Marco
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

10.  Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease.

Authors:  M J Kern; P Ganz; J D Horowitz; J Gaspar; W H Barry; B H Lorell; W Grossman; G H Mudge
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

View more
  2 in total

1.  Integrating Physiology into the DNA of Coronary Revascularisation - A Historical Perspective, Contemporary Review and Blueprint for the Future of Coronary Physiology.

Authors:  Sen Sayan; Justin Davies
Journal:  Interv Cardiol       Date:  2015-05

2.  Invasive minimal Microvascular Resistance Is a New Index to Assess Microcirculatory Function Independent of Obstructive Coronary Artery Disease.

Authors:  Guus A de Waard; Sukhjinder S Nijjer; Martijn A van Lavieren; Nina W van der Hoeven; Ricardo Petraco; Tim P van de Hoef; Mauro Echavarría-Pinto; Sayan Sen; Peter M van de Ven; Paul Knaapen; Javier Escaned; Jan J Piek; Justin E Davies; Niels van Royen
Journal:  J Am Heart Assoc       Date:  2016-12-22       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.